dc.contributor.author |
Madina Bohodirovna Rakhimova, Khalmurad Sadullaevich Akhmedov, Sagdiyana Nasurullaevna Buranova |
|
dc.date.accessioned |
2022-10-05T14:58:26Z |
|
dc.date.available |
2022-10-05T14:58:26Z |
|
dc.date.issued |
2022 |
|
dc.identifier.citation |
Тошкент |
en_US |
dc.identifier.issn |
2181-5534 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/2442 |
|
dc.description.abstract |
Despite the fact that the attention of a huge number of researchers around the world is focused on the development of effective clinical protocols and recommendations for the management of patients with a new coronavirus infection, the presence of a large number of severe forms of the disease and deaths allows usto count, that to date, doctors have not formed a holistic picture of the pathogenesis of this disease, enabling effective atment and prevention of critical complications. In a number of studies in patients with severe COVID-19, a statistically significant association was found between the detection of icrotrombs in the pulmonary vessels, disorders of the coagulation balance and damage to the vascular endothelium [1, 2, 3]. However, when describing the pathogenesis of COVID-19, as well as the factors involved in the development of complications of a new coronavirus infection, insufficient attention is paid to endothelial dysfunction. |
en_US |
dc.language.iso |
other |
en_US |
dc.relation.ispartofseries |
УДK;616.721-002.77-085.814.1: 578.834.1 |
|
dc.subject |
Effect of the CD147 marker (basigin, EMMPRIN, transmembrane serine protease) on the development of endothelial damage in COVID-19 |
en_US |
dc.title |
Endothelial dysfunction as a link in COVID-19 pathogenesis |
en_US |
dc.type |
Article |
en_US |